Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

27.95INR
18 May 2018
Change (% chg)

Rs-1.05 (-3.62%)
Prev Close
Rs29.00
Open
Rs29.40
Day's High
Rs29.70
Day's Low
Rs27.80
Volume
1,362,709
Avg. Vol
2,932,350
52-wk High
Rs52.30
52-wk Low
Rs25.30

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Mark Saldanha

2007 Executive Non-Independent Chairman of the Board, Managing Director

Harshavardhan Panigrahi

2009 Compliance Officer, Company Secretary, Legal Manager

Vinay Nayak

2016 Whole-time Director

Sandra Saldanha

42 2014 Whole-time Director

Digant Parikh

2018 Independent Director